On April 7, 2022 Labcorp (NYSE: LH), a leading global life sciences company, reported that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock (Press release, LabCorp, APR 7, 2022, View Source [SID1234611591]). The dividend will be payable on June 9, 2022, to stockholders of record as of the close of business on May 19, 2022.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The declaration and payment of the dividend is consistent with Labcorp’s previously announced intention to initiate paying quarterly dividends beginning in the second quarter of 2022. Labcorp currently expects to continue to pay quarterly cash dividends, with future declarations subject to Board approval at its discretion. The decision of whether to pay future dividends and the amount of dividends will be based on Labcorp’s financial position, results of operations, cash flows, capital requirements, applicable law, and any other factors the Board may deem relevant.